Bank of New York Mellon Corp Has $14.30 Million Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Bank of New York Mellon Corp decreased its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 4.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 170,481 shares of the medical instruments supplier's stock after selling 8,266 shares during the quarter. Bank of New York Mellon Corp owned 0.75% of LeMaitre Vascular worth $14,303,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of LMAT. Raymond James Financial Inc. acquired a new position in shares of LeMaitre Vascular during the 4th quarter worth approximately $14,900,000. Rockefeller Capital Management L.P. acquired a new position in LeMaitre Vascular in the 4th quarter valued at $7,787,000. Segall Bryant & Hamill LLC acquired a new position in LeMaitre Vascular in the 4th quarter valued at $5,446,000. Invesco Ltd. raised its holdings in LeMaitre Vascular by 50.5% in the 4th quarter. Invesco Ltd. now owns 174,998 shares of the medical instruments supplier's stock valued at $16,124,000 after acquiring an additional 58,720 shares during the last quarter. Finally, GAMMA Investing LLC raised its holdings in LeMaitre Vascular by 7,486.5% in the 1st quarter. GAMMA Investing LLC now owns 53,864 shares of the medical instruments supplier's stock valued at $4,519,000 after acquiring an additional 53,154 shares during the last quarter. Hedge funds and other institutional investors own 84.64% of the company's stock.

Insider Activity

In related news, CEO George W. Lemaitre sold 4,399 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $85.10, for a total transaction of $374,354.90. Following the completion of the sale, the chief executive officer directly owned 1,827,003 shares in the company, valued at approximately $155,477,955.30. This trade represents a 0.24% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 100,000 shares of company stock valued at $8,556,857 in the last ninety days. 9.50% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Separately, Barrington Research reiterated a "market perform" rating on shares of LeMaitre Vascular in a report on Tuesday. Five research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $97.83.

LeMaitre Vascular Trading Up 2.2%

Shares of LMAT stock traded up $1.77 on Wednesday, reaching $82.16. 119,320 shares of the stock were exchanged, compared to its average volume of 168,842. The stock has a market cap of $1.86 billion, a P/E ratio of 41.49, a price-to-earnings-growth ratio of 2.12 and a beta of 0.82. The company has a quick ratio of 13.83, a current ratio of 16.49 and a debt-to-equity ratio of 0.48. The firm has a 50 day moving average of $82.69 and a two-hundred day moving average of $87.55. LeMaitre Vascular, Inc. has a 1-year low of $71.42 and a 1-year high of $109.58.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.50 by ($0.02). LeMaitre Vascular had a net margin of 19.96% and a return on equity of 13.53%. The firm had revenue of $59.87 million for the quarter, compared to analysts' expectations of $57.61 million. During the same quarter in the prior year, the business earned $0.44 EPS. The company's revenue for the quarter was up 12.0% on a year-over-year basis. On average, research analysts anticipate that LeMaitre Vascular, Inc. will post 1.94 EPS for the current year.

LeMaitre Vascular Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date was Thursday, May 15th. LeMaitre Vascular's payout ratio is currently 40.40%.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.